Spinal muscular atrophy approval boosts antisense drugs

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dolgin, E. Spinal muscular atrophy approval boosts antisense drugs. Nat Biotechnol 35, 99–100 (2017). https://doi.org/10.1038/nbt0217-99

Download citation

Further reading